Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00322647 · ClinicalTrials.gov registry record
Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 20
- Enrollment target
NCT00322647 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 20 participants.
The verdict
NCT00322647 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
1. To identify reasons for low patient recruitment numbers to clinical trials in a cancer research center setting (and a community setting) in order to attempt to increase accrual rates. 2. To review the screening sheet for women who considered participating in the study of Tamoxifen and Raloxifene (STAR) for the prevention of breast cancer in high risk women through the University of New Mexico in Albuquerque from 1999 through 2004
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00322647
The ClinicalTrials.gov registry entry for NCT00322647 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00322647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00322647 about?
NCT00322647 is a clinical study titled "Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting". 1. To identify reasons for low patient recruitment numbers to clinical trials in a cancer research center setting (and a community setting) in order to attempt to increase accrual rates. 2. To review the screening sheet for women who considered participating in the study of Tamoxifen and Raloxifene ...
What is the current status of trial NCT00322647?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-01. Estimated completion is 2007-06.
Who is sponsoring clinical trial NCT00322647?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.